CANGRELOR

CANGRELOR was reported 404 times

These side effects are most commonly reported by patients taking CANGRELOR:

# Side effect Count
0 OFF LABEL USE 160
1 VASCULAR STENT THROMBOSIS 32
2 DRUG INEFFECTIVE 31
3 HAEMORRHAGE 26
4 DEATH 22
5 NO ADVERSE EVENT 20
6 CARDIAC ARREST 18
7 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18
8 CARDIOGENIC SHOCK 15
9 GASTROINTESTINAL HAEMORRHAGE 14
10 DYSPNOEA 12
11 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12
12 CEREBRAL HAEMORRHAGE 11
13 INTENTIONAL PRODUCT USE ISSUE 11
14 HAEMORRHAGE INTRACRANIAL 10
15 CARDIAC FAILURE 9
16 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9
17 VASCULAR ACCESS SITE HAEMORRHAGE 9
18 EOSINOPHILIA 8
19 INCORRECT DRUG ADMINISTRATION RATE 8
20 PULMONARY HAEMORRHAGE 8
21 THROMBOCYTOPENIA 8
22 THROMBOSIS 8
23 CEREBROVASCULAR ACCIDENT 7
24 HYPOTENSION 7
25 MIXED LIVER INJURY 7
26 MYOCARDIAL INFARCTION 7
27 VENTRICULAR FIBRILLATION 7
28 INCORRECT DOSE ADMINISTERED 6
29 INCORRECT PRODUCT ADMINISTRATION DURATION 6
30 STEVENS-JOHNSON SYNDROME 6
31 VENTRICULAR TACHYCARDIA 6
32 CHEST PAIN 5
33 DRUG INTERACTION 5
34 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5
35 HAEMATOMA 5
36 HAEMOGLOBIN DECREASED 5
37 HEPARIN-INDUCED THROMBOCYTOPENIA 5
38 ILL-DEFINED DISORDER 5
39 PRODUCT PREPARATION ERROR 5
40 ACUTE MYOCARDIAL INFARCTION 4
41 BRADYCARDIA 4
42 DELIRIUM 4
43 DRUG RESISTANCE 4
44 HAEMATURIA 4
45 HEADACHE 4
46 MOUTH HAEMORRHAGE 4
47 PULMONARY ALVEOLAR HAEMORRHAGE 4
48 RETROPERITONEAL HAEMORRHAGE 4
49 THERAPY NON-RESPONDER 4
50 TRACHEAL HAEMORRHAGE 4
51 CONTUSION 3
52 CORONARY REVASCULARISATION 3
53 DRUG ABUSE 3
54 DRUG ADMINISTRATION ERROR 3
55 DRUG LEVEL DECREASED 3
56 GASTRIC HAEMORRHAGE 3
57 GASTRITIS HAEMORRHAGIC 3
58 HAEMORRHAGIC STROKE 3
59 HAEMOTHORAX 3
60 INTRACRANIAL ANEURYSM 3
61 INTRAVENTRICULAR HAEMORRHAGE 3
62 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3
63 NAUSEA 3
64 PERICARDIAL EFFUSION 3
65 PNEUMOTHORAX 3
66 PRODUCT ADMINISTRATION ERROR 3
67 PRODUCT COMPLAINT 3
68 PRODUCT USE ISSUE 3
69 PULMONARY OEDEMA 3
70 RESPIRATORY FAILURE 3
71 SHOCK 3
72 SUBARACHNOID HAEMORRHAGE 3
73 TRANSFUSION 3
74 ACUTE CORONARY SYNDROME 2
75 ACUTE KIDNEY INJURY 2
76 ARTERIAL HAEMORRHAGE 2
77 ARTERIOSCLEROSIS 2
78 ATRIOVENTRICULAR BLOCK 2
79 CARDIAC FAILURE CONGESTIVE 2
80 CARDIAC TAMPONADE 2
81 CARDIO-RESPIRATORY ARREST 2
82 CATHETER SITE HAEMORRHAGE 2
83 CONDITION AGGRAVATED 2
84 CONTRAINDICATED PRODUCT ADMINISTERED 2
85 CORONARY ARTERY DISSECTION 2
86 EJECTION FRACTION DECREASED 2
87 EPISTAXIS 2
88 EXPOSURE DURING PREGNANCY 2
89 HAEMATOCRIT DECREASED 2
90 HAEMOPTYSIS 2
91 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 2
92 HYPERHIDROSIS 2
93 HYPERTENSIVE EMERGENCY 2
94 HYPOXIA 2
95 INFUSION RELATED REACTION 2
96 INFUSION SITE EXTRAVASATION 2
97 INFUSION SITE SWELLING 2
98 INTERNATIONAL NORMALISED RATIO INCREASED 2
99 LUNG INFILTRATION 2
100 OVERDOSE 2
101 PELVIC VENOUS THROMBOSIS 2
102 PERICARDIAL HAEMORRHAGE 2
103 PROCEDURAL HAEMORRHAGE 2
104 PRODUCT NAME CONFUSION 2
105 PRODUCT QUALITY ISSUE 2
106 PRODUCT RECONSTITUTION ISSUE 2
107 RASH 2
108 RECTAL HAEMORRHAGE 2
109 RENAL FAILURE 2
110 SEPSIS 2
111 SINOATRIAL BLOCK 2
112 THERAPEUTIC RESPONSE UNEXPECTED 2
113 THROMBOPHLEBITIS 2
114 TYPE 2 DIABETES MELLITUS 2
115 UNDERDOSE 2
116 VENA CAVA THROMBOSIS 2
117 VOMITING 2
118 ABDOMINAL DISCOMFORT 1
119 ACIDOSIS 1
120 ACUTE RESPIRATORY DISTRESS SYNDROME 1
121 ACUTE RESPIRATORY FAILURE 1
122 ADMINISTRATION SITE INDENTATION 1
123 ADVERSE EVENT 1
124 ANAEMIA 1
125 ANAPHYLACTIC REACTION 1
126 ANAPHYLACTIC SHOCK 1
127 ANASTOMOTIC ULCER HAEMORRHAGE 1
128 ANXIETY 1
129 ARTERIAL OCCLUSIVE DISEASE 1
130 ASTHENIA 1
131 ATRIAL FLUTTER 1
132 ATRIAL THROMBOSIS 1
133 BLOOD CREATININE INCREASED 1
134 BLOOD LOSS ANAEMIA 1
135 BLOOD PRESSURE DECREASED 1
136 BLOOD PRESSURE INCREASED 1
137 BRADYARRHYTHMIA 1
138 BRAIN CONTUSION 1
139 BRAIN DEATH 1
140 BRAIN HERNIATION 1
141 BRAIN OEDEMA 1
142 BRONCHIAL HAEMORRHAGE 1
143 BURKHOLDERIA INFECTION 1
144 BURKHOLDERIA TEST POSITIVE 1
145 CARDIAC FAILURE ACUTE 1
146 CARDIAC VENTRICULAR THROMBOSIS 1
147 CATHETER SITE HAEMATOMA 1
148 CATHETER SITE SWELLING 1
149 CENTRAL NERVOUS SYSTEM LESION 1
150 CEREBRAL HYPOPERFUSION 1
151 CHEST DISCOMFORT 1
152 CHROMATURIA 1
153 CLONUS 1
154 COAGULATION TIME ABNORMAL 1
155 COLITIS ISCHAEMIC 1
156 COMA 1
157 COMPARTMENT SYNDROME 1
158 CONSTIPATION 1
159 CORONARY ARTERY DISEASE 1
160 CORONARY ARTERY OCCLUSION 1
161 CORONARY ARTERY RESTENOSIS 1
162 CORONARY ARTERY THROMBOSIS 1
163 COUGH 1
164 CRANIOCEREBRAL INJURY 1
165 DECREASED APPETITE 1
166 DEPRESSED LEVEL OF CONSCIOUSNESS 1
167 DIARRHOEA 1
168 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1
169 DIZZINESS 1
170 DOSE CALCULATION ERROR 1
171 DRUG EFFECT DECREASED 1
172 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
173 DRUG HYPERSENSITIVITY 1
174 DUODENAL ULCER HAEMORRHAGE 1
175 DUODENITIS HAEMORRHAGIC 1
176 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1
177 EOSINOPHIL CATIONIC PROTEIN INCREASED 1
178 ERUCTATION 1
179 ERYTHEMA 1
180 EXTRAVASATION 1
181 EYE HAEMORRHAGE 1
182 FALL 1
183 FALSE NEGATIVE INVESTIGATION RESULT 1
184 FATIGUE 1
185 FEEDING DISORDER 1
186 FLATULENCE 1
187 GAIT DISTURBANCE 1
188 GASTRIC ULCER HAEMORRHAGE 1
189 GENERALISED TONIC-CLONIC SEIZURE 1
190 GLOSSODYNIA 1
191 GRAFT HAEMORRHAGE 1
192 GRAFT THROMBOSIS 1
193 HAEMORRHAGIC TRANSFORMATION STROKE 1
194 HEAD INJURY 1
195 HEMIPARESIS 1
196 HEPATIC FAILURE 1
197 HOSPITALISATION 1
198 HYDROCEPHALUS 1
199 HYPERGLYCAEMIA 1
200 HYPERSENSITIVITY 1
201 HYPERTHERMIA 1
202 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
203 INCORRECT DOSAGE ADMINISTERED 1
204 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
205 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1
206 INFUSION SITE BRUISING 1
207 INFUSION SITE IRRITATION 1
208 INSOMNIA 1
209 INTESTINAL HAEMORRHAGE 1
210 INTESTINAL ISCHAEMIA 1
211 INTRACRANIAL PRESSURE INCREASED 1
212 LABELLED DRUG-DRUG INTERACTION ISSUE 1
213 LACTIC ACIDOSIS 1
214 MEDICATION ERROR 1
215 METASTASIS 1
216 MUSCLE SPASMS 1
217 MUSCULAR WEAKNESS 1
218 MYALGIA 1
219 NEPHROPATHY TOXIC 1
220 NEUROLOGICAL DECOMPENSATION 1
221 NEUROLOGICAL SYMPTOM 1
222 OEDEMA PERIPHERAL 1
223 OESOPHAGEAL ULCER HAEMORRHAGE 1
224 OXYGEN SATURATION DECREASED 1
225 PACKED RED BLOOD CELL TRANSFUSION 1
226 PAIN 1
227 PANCREATITIS 1
228 PARAESTHESIA ORAL 1
229 PELVIC HAEMATOMA 1
230 PEPTIC ULCER HAEMORRHAGE 1
231 PERIPHERAL ISCHAEMIA 1
232 PLATELET ADHESIVENESS DECREASED 1
233 PLATELET COUNT DECREASED 1
234 PLATELET FUNCTION TEST ABNORMAL 1
235 PNEUMONIA ASPIRATION 1
236 PNEUMONIA PSEUDOMONAS AERUGINOSA 1
237 POST PROCEDURAL HAEMATOMA 1
238 POST PROCEDURAL HAEMORRHAGE 1
239 PRESCRIBED OVERDOSE 1
240 PROCEDURAL SHOCK 1
241 PRODUCT CONTAMINATION MICROBIAL 1
242 PRODUCT DOSE OMISSION ISSUE 1
243 PRODUCT PREPARATION ISSUE 1
244 PRODUCT USE IN UNAPPROVED INDICATION 1
245 PRODUCTIVE COUGH 1
246 PULMONARY FUNCTION TEST DECREASED 1
247 PULMONARY VENOUS HYPERTENSION 1
248 RASH ERYTHEMATOUS 1
249 RECALLED PRODUCT 1
250 RENAL FAILURE ACUTE 1
251 RENAL IMPAIRMENT 1
252 RESPIRATORY DEPRESSION 1
253 RESPIRATORY DISTRESS 1
254 RESPIRATORY GAS EXCHANGE DISORDER 1
255 RESPIRATORY TRACT HAEMORRHAGE 1
256 RESTENOSIS 1
257 RETROPERITONEAL HAEMATOMA 1
258 SMALL INTESTINAL HAEMORRHAGE 1
259 SPUTUM CULTURE POSITIVE 1
260 SUBDURAL HAEMATOMA 1
261 SUBDURAL HAEMORRHAGE 1
262 SYNCOPE VASOVAGAL 1
263 SYSTOLIC DYSFUNCTION 1
264 THERAPEUTIC PRODUCT EFFECT DECREASED 1
265 THROMBOSIS IN DEVICE 1
266 TONGUE PIGMENTATION 1
267 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1
268 TRAUMATIC HAEMOTHORAX 1
269 TRAUMATIC LIVER INJURY 1
270 TREATMENT NONCOMPLIANCE 1
271 TROPONIN INCREASED 1
272 UNRESPONSIVE TO STIMULI 1
273 URTICARIA 1
274 VASCULAR PSEUDOANEURYSM 1
275 VASCULAR STENT OCCLUSION 1
276 VASOGENIC CEREBRAL OEDEMA 1
277 VENTRICULAR HYPOKINESIA 1
278 VESSEL PUNCTURE SITE HAEMORRHAGE 1
279 VISUAL IMPAIRMENT 1